What drove 4564.T stock to be most active after hours today?

High trade interest was driven by volume of **48,921,400.00** shares and upcoming catalysts, notably a May earnings announcement and several clinical trial milestones that raise event risk and trading activity.

What is Meyka AI's view and forecast for 4564.T stock?

Meyka AI rates 4564.T **69.32 / B (HOLD)** and forecasts a 12-month price of **JPY 17.31**, implying a **-13.45%** downside from **JPY 20.00**. Forecasts are model-based and not guarantees.

What are the main valuation metrics for OncoTherapy (4564.T)?

Key metrics: **Price JPY 20.00**, **EPS -2.83**, **PE -7.07**, **P/B 3.37**, **P/S 8.76**, and market cap **JPY 6,872,871,980.00**, showing biotech-stage valuation with negative earnings.

How should traders approach 4564.T ahead of earnings and trials?

Traders should use position sizing and stop limits given ATR **1.39** and high volatility; consider short-term trades around technical levels (BB **19.50–21.50**) and avoid large directional exposure before binary events.

JP Stocks

Most Active After Hours Mar 2026: 4564.T OncoTherapy JPX JPY 20.00: Earnings risk

ByDanny Kontos March 6, 2026March 6, 2026

The stock 4564.T stock (OncoTherapy Science, Inc., JPX) traded as one of Japan’s most active after-hours issues on 06 Mar 2026, closing at JPY 20.00 on heavy turnover. Volume reached 48,921,400.00 shares versus an average of 42,866,803.00, marking a relative volume of 1.14 and signalling focused interest ahead of a May earnings event. Market moves reflect clinical progress, short-term technical weakness and a narrow market cap of JPY 6,872,871,980.00, creating a high-volatility setup for traders and longer-term watchers.